Selecting and Auditing a Technology Vendor for Biopharmaceutical Development

Jun 08, 2017

Register Free:

Technology and the pharmaceutical world are becoming more entwined every day. Traditionally, technology suppliers have had difficulty in embracing the regulated world of pharmaceuticals.  In turn, the pharmaceutical world has looked to apply rigorous standards to software companies. To compound matters, the regulations around software are both outdated and vague.

  • What constitutes “regulatory-ready” software?
  • What does quality look like for software being used in a regulated industry?
  • How do you determine if software has been developed to support a regulated industry?
  • How can the two coexist?

Demystifying the selection and auditing process of technology vendors in biopharmaceutical development



Bill Kane MBA, ASQ CQA, CCCP, Director of Quality Assurance, Almac Clinical Technologies

Matt Lowrie ASQ, CQA, Group Leader Quality Assurance, Almac Clinical Technologies


Recorded date: June 8, 2017 / On Demand available until June 8, 2018.

Register Free:

lorem ipsum